secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001193125-23-278858
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences SPAC to acquire OSR Holdings Co., Ltd. in share exchange
-------------------------------------------------------------------------------

- BLAC entered Business Combination Agreement to acquire at least 60% of OSR shares; minimum $5M+ cash in trust condition.
- Transaction requires BLAC stockholder approval, HSR clearance, and at least 60% of OSR holders to participate; outside date May 14, 2024.
- BLAC issued $180,000 unsecured promissory note to sponsor Bellevue Capital Management; due at closing or Dec 31, 2024.
- CEO Kuk Hyoun Hwang serves as CEO of both BLAC and OSR; M&A Committee of independent directors approved deal.
- BLAC adopted clawback policy to comply with Nasdaq listing standards under Section 10D of Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/d881994d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-278858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer